Company: ZVRA
Filing Date: 2025-04-21
Form Type: DEFC14A
Source: 0001193125-25-086293
Chunk: 52

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-21
Form: DEFC14A
Chunk 52
---
 Date. |

| (9) | Consists of (a) 40,000 shares of common stock held directly by Mr. Bode and (b) 52,266 shares of common stock underlying options that are exercisable within 60 days of the Record Date. |

| (10) | Consists of 52,266 shares of common stock underlying options that are exercisable within 60 days of the Record Date. |

| (11) | Consists of 52,266 shares of common stock underlying options that are exercisable within 60 days of the Record Date. |

50

| (12) | Consists of (a) 719 shares of common stock directly held by Ms. Favorito and (b) 135,900 shares of common stock underlying options that are exercisable within 60 days of the Record Date. |

| (13) | Consists of 27,766 shares of common stock underlying options that are exercisable within 60 days of the Record Date. |

| (14) | Consists of (a) 1,800 shares of common stock directly held by Mr. Watton and (b) 52,266 shares of common stock underlying options that are exercisable within 60 days of the Record Date. |

| (15) | Consists of (a) 337,805 shares of common stock and (b) 1,174,521 shares of common stock underlying options that are exercisable within 60 days of the Record Date. |

51

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act requires the Company’s directors and executive officers, and persons who own more than ten percent of a registered class of the Company’s equity securities, or collectively, the Reporting Persons, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than ten percent stockholders are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms they file.

To the Company’s knowledge, based solely on a review of the copies of such forms filed with the SEC and written representations of the Reporting Persons received by us, during the year ended December 31, 2024, all required Section 16 reports under the Exchange Act for our directors, officers, and beneficial owners of greater than 10% of our common stock were filed on a timely basis other than (i) those previously reported in